HEMOSTASIS 
DiaPharma is a trusted partner in all things hemostasis, known to offer the most cutting edge tools and testing options for clinical and research laboratories. From FVIII and FIX assays for Hemophilia A & B, to FDA-cleared novel options for total platelet function assessment using the TTAS® 01, to fully automated TGA and ADAMTS13 analysis with the Ceveron® s100, series… DiaPharma has the hottest topics covered.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
NEWS + EVENTS
Celebrate 35 years of Technoclone and a Special Ceveron® s100 price
Posted: November 15, 2022Thank you for visiting us at The Li...
Posted: November 11, 2022
FEATURED PRODUCT
We are acutely aware that liver diseases, like Alcoholic Hepatitis and NASH, are increasingly recognized as major health problems in the U.S., yet there are still no FDA-approved pharmacological treatments for either. Liver diseases are an under recognized health burden that are subtracting from our world’s quality of life and productivity. DiaPharma is invested in providing non-invasive blood biomarkers to measure the effect of potential drug candidates in NASH clinical trials. LEARN MORE